Premature ovarian failure: etiology and prospects

References

• Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986; 67: 604–6
   PubMed Web of Science ®Google Scholar
• O'Herlihy C, Peperell RC, Evans JH. The significance of FSH elevation in young women with disorders of ovulation. Br Med J 1980; 281: 1447–50
   PubMed Web of Science ®Google Scholar
• Atria A. La menopausia precoz y tratamiento hormonal. Rev Med Chil 1950; 78: 373–7
   Google Scholar
• Jones GS, de Moraes-Ruehsen M. A new syndrome of amenorrhea in association with hypergonadotropism and apparently normal ovarian follicular apparatus. Am J Obstet Gynecol 1969; 104: 597–600
   PubMed Web of Science ®Google Scholar
• Goldenberg RL, Grodin RL, Rodbard D, et al. Gonadotropins in women with amenorrhea. Am J Obstet Gynecol 1973; 116: 1003–9
   Google Scholar
• Rebar RW, Conolly HV. Clinical features of young women with hypergonadotropic amenorrhea. Fertil Steril 1990; 53: 804–10
   PubMed Web of Science ®Google Scholar
• Conway GS, Kaltsas G, Patel A, et al. Characterization of idiopathic premature ovarian failure. Fertil Steril 1996; 65: 337–41
   PubMed Web of Science ®Google Scholar
• Nelson LM, Anasti JN, Kimzey LM, et al. Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. J Clin Endocrinol Metab 1994; 79: 1470–5
   PubMed Web of Science ®Google Scholar
• Mehta AE, Matwijiw I, Lyons EA, et al. Noninvasive diagnosis of resistant ovary syndrome by ultrasonography. Fertil Steril 1992; 57: 56–61
   PubMed Web of Science ®Google Scholar
• Kinch RAH, Plunkett ER, Smout MS, et al. Primary ovarian failure: a clinicopathological and cytogenetic study. Am J Obstet Gynecol 1965; 91: 630–41
   Google Scholar
• Amsterdam A, Dantes A, Selvaraj N, et al. Apoptosis in steroidogenetic cells: structure-function analysis. Steroids 1997; 62: 207–11
   PubMedGoogle Scholar
• Kaipa A, Hsueh AJ. Regulation of ovarian follicle atresia. Annu Rev Physiol 1997; 59: 349–63
   Google Scholar
• Hsueh AJ, Eisenhauer K, Chun SY, et al. Gonadal cell apoptosis. Recent Prog Horm Res 1996; 51: 433–56
   PubMedGoogle Scholar
• Dewhurst CJ, De Koos EB, Ferreira HP. The resistant ovary syndrome. Br J Obstet Gynecol 1975; 82: 341–5
   PubMedGoogle Scholar
• Maxson WS, Wentz AC. The gonadotropin resistant ovary syndrome. Semin Reprod Endocrinol 1983; 1: 147–60
   Google Scholar
• Anasti JN. Premature ovarian failure: an update. Fertil Steril 1998; 70: 1–15
   PubMed Web of Science ®Google Scholar
• Davies SR. Premature ovarian failure. Maturitas 1996; 23: 1–8
   Google Scholar
• Coulam CB. Age, estrogens, and the psyche. Clin Obstet Gynaecol 1981; 24: 219–29
   Google Scholar
• Plouffe L, McDonough PG. Ovarian agenesis and dysgenesis. Reproductive Endocrinology, Surgery, and Technology 1st edn., EY Adashi, JA Rock, Z Rosenwaks. Lippincott-Raven, New York 1995; 1365–84
   Google Scholar
• Letur-Konirsch H, Guis F. Recovery of ovarian function after radiation-induced menopause. Does follicle-stimulating hormone (FSH) have a definitive prognostic value?. CR Acad Sci III 1996; 319: 907–12
   PubMedGoogle Scholar
• Boyers SP, Luborsky JL, De Cherney AH. Usefulness of serial measurements of serum follicle stimulating hormone, luteinizing hormone and estradiol in patients with premature ovarian failure. Fertil Steril 1988; 50: 408–12
   PubMedGoogle Scholar
• Scott RT, Hofmann GE. Prognostic assessment of ovarian reserve. Fertil Steril 1995; 63: 1–11
   PubMed Web of Science ®Google Scholar
• Farhi J, Homburg R, Ferber A, et al. Non-response to ovarian failure stimulation in normogonadotrophic, normogonadal women: a clinical sign of impending onset of ovarian failure pre-empting the rise in basal follicle stimulating hormone levels. Hum Reprod 1997; 12: 241–3
   PubMedGoogle Scholar
• Kim TJ, Anasti JN, Flack MR, et al. Routine endocrine screening for patients with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol 1997; 89: 777–9
   PubMed Web of Science ®Google Scholar
• Daneshdoost L, Gennarelli TA, Bashey HM, et al. Recognition of gonadotroph adenomas in women. N Engl J Med 1991; 324: 589–94
   PubMed Web of Science ®Google Scholar
• Olivar AC. The role of laparoscopic ovarian biopsy in the management of premature gonadal failure. Conn Med 1996; 60: 707–8
   PubMedGoogle Scholar
• Conway GS, Kaltsas G, Patel A, et al. Characterization of idiopathic premature ovarian failure. Fertil Steril 1996; 65: 337–41
   PubMed Web of Science ®Google Scholar
• Khastgir G, Abdalla H, Studd JWW. The case against ovarian biopsy for the diagnosis of premature menopause. Br J Obstet Gynaecol 1994; 101: 96–8
   PubMedGoogle Scholar
• Eden JA. Ovarian biopsy for diagnosis of premature menopause (letter). Br J Obstet Gynaecol 1994; 101: 925
   PubMedGoogle Scholar
• La Barbera AR, Miller MM, Rebar RW. Autoimmune etiology in premature ovarian failure. Am J Reprod Immunol 1998; 16: 115–22
   Google Scholar
• Uibo R, Aavik E, Peterson P, et al. Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450 c21 in autoimmune polyglandular disease types I and II and in isolated Addison's disease. J Clin Endocrinol Metab 1994; 78: 323–8
   PubMedGoogle Scholar
• Winqvist O, Gebre-Medhin G, Gustafsson J, et al. Identification of the main gonadal autoantigens in patients with adrenal insufficiency and associated ovarian failure. J Clin Endocrinol Metab 1995; 80: 1717–23
   Google Scholar
• Mignot MH, Schoemaker L, Kleingeld M, et al. Premature ovarian failure I: the association with autoimmunity. Eur J Obstet Gynecol Reprod Biol 1989; 30: 59–66
   PubMedGoogle Scholar
• Damewood MD, Zacur HA, Hoffman GF, et al. Circulating anti-ovarian antibodies in premature ovarian failure. Obstet Gynaecol 1986; 68: 850–4
   PubMed Web of Science ®Google Scholar
• Luborsky JL, Visintin I, Boyers S, et al. Ovarian antibodies detected by immobilized antigen immunoassay in patients with premature ovarian failure. J Clin Endocrinol Metab 1990; 70: 69–75
   PubMed Web of Science ®Google Scholar
• Moncayo R, Moncayo HE. Autoimmunity and the ovary. Immunol Today 1992; 13: 225–58
   Google Scholar
• Wheatcroft NJ, Toogood AA, Li TC, et al. Detection of antibodies to ovarian antigens in women with premature ovarian failure. Clin Exp Immunol 1994; 96: 122–8
   PubMedGoogle Scholar
• Gobert B, Barbarino-Monnier P, Guillet-Rosso F, et al. Ovary antibodies after IVF. Lancet 1990; 335: 723
   Google Scholar
• Coulam CB, Ryan RJ. Prevalence of circulating antibodies directed toward ovaries among women with premature ovarian failure. Am J Reprod Immunol Microbiol 1985; 9: 23–4
   PubMedGoogle Scholar
• Russell P, Babbatyne P. Surgical Pathology of the Ovaries. Churchill Livingstone, Edinburgh 1995; 57
   Google Scholar
• Friedman CI, Gurgen-Varol F, Lucas J, et al. Persistent progesterone production associated with autoimmune oophoritis – a case report. J Reprod Med 1987; 32: 293–6
   Google Scholar
• Biscotti CV, Hart WR, Lucas JG. Cystic ovarian enlargement resulting from autoimmune oophoritis. Obstet Gynecol 1989; 74: 492–5
   PubMed Web of Science ®Google Scholar
• Gloor E, Hurlimann J. Autoimmune oophoritis. Am J Clin Pathol 1984; 81: 105–9
   PubMed Web of Science ®Google Scholar
• Scdmak DD, Hart WR, Tubbs RR. Autoimmune oophoritis: a histopathologic study of involved ovaries with immunologic characterisation of the mononuclear cell infiltrate. Int J Gynecol Pathol 1987; 6: 73–81
   Google Scholar
• Bannatyne P, Russel P, Shearman RP. Autoimmune oophoritis: a clinicopathologic assessment of 12 cases. Int J Gynecol Pathol 1990; 9: 191–207
   PubMedGoogle Scholar
• Pekonen F, Siegberg R, Makinen T, et al. Immunological disturbances in patients with premature ovarian failure. Clin Endocrinol 1986; 25: 1–6
   PubMedGoogle Scholar
• Young RH, Scully RE. Sex cord-stromal, steroid cell, and other ovarian tumors with endocrine, paraendocrine, and paraneoplastic manifestations. Blaustein's Pathology of the Female Genital Tract, R Kurman. Springer Verlag, New York 1987; 607–58
   Google Scholar
• Pujol-Borrell R, Londei M, Foulis A, et al. Inappropriate major histocompatibility complex class II expression by thyroid follicular cells in autoimmune disease and by pancreatic beta cells in type I diabetes. Mol Biol Med 1986; 3: 159–65
   Google Scholar
• Hoek A, Schoemaker J, Drexhage HA. Premature ovarian failure and ovarian autoimmunity. Endocr Rev 1997; 18: 107–34
   PubMed Web of Science ®Google Scholar
• Tidey GF, Nelson LM, Phillips TM. Gonadotropins enhance HLA-DR antigen expression in human granulosa cells. Am J Obstet Gynecol 1992; 167: 1768–73
   PubMed Web of Science ®Google Scholar
• Morrison JC, Givens JR, Wiser WL, et al. Mumps oophoritis: a cause of premature menopause. Fertil Steril 1975; 26: 655–9
   PubMed Web of Science ®Google Scholar
• Bottazzo GF, Pujol-Borrell R, Hanafusa T, et al. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 1983; 2: 1115–8
   PubMed Web of Science ®Google Scholar
• Kreuser ED, Hetzel WD, Billia DO, et al. Gonadal toxicity following cancer therapy in adults: significance, diagnosis, prevention and treatment. Cancer Treat Rev 1990; 17: 169–75
   PubMed Web of Science ®Google Scholar
• Howell S, Shalet S. Gonadal damage from chemotherapy and radiotherapy. Endocrinol Metab Clin North Am 1998; 27: 927–43
   PubMed Web of Science ®Google Scholar
• Young RH, Scully RE. Ovarian pathology of infertility. Pathology of Reproductive Failure, FT Kraus, I Damjanov, N Kaufman. Williams & Wilkins, Baltimore 1991; 104–39
   Google Scholar
• Stillman RJH, Schinfeld JS, Schiff I, et al. Ovarian failure in long-term survivors of childhood malignancy. Am J Obstet Gynecol 1981; 139: 62–6
   PubMed Web of Science ®Google Scholar
• Gradishar WJ, Schilsky RL. Ovarian function following radiation and chemotherapy. Semin Oncol 1989; 16: 425–36
   PubMed Web of Science ®Google Scholar
• Wallace WH, Shalet SM, Crowne EC, et al. Ovarian failure following abdominal irradiation in childhood: natural history and prognosis. Clin Oncol R Coll Radiol 1989; 1: 75–9
   Google Scholar
• Verp MS. Environmental causes of ovarian failure. Semin Reprod Endocrinol 1983; 1: 101–11
   Google Scholar
• Schulz-Lobmeyr I, Schratter-Sehn A, Huber J, et al. Laparoscopic lateral ovarian transposition before pelvic irradiation for a non Hodgkin lymphoma. Acta Obstet Gynecol Scand 1999; 78: 350–2
   Google Scholar
• Byrne J, Mulvihill JJ, Myers MH, et al. Effects of treatment on fertility in long term-survivors of childhood cancer. N Engl J Med 1987; 317: 1315–21
   PubMed Web of Science ®Google Scholar
• Ataya K, Moghissi K. Chemotherapy induced premature ovarian failure: mechanism and prevention. Steroids 1989; 54: 607–27
   PubMedGoogle Scholar
• Kumar R, Biggart JD, McEnvoy J, et al. Cyclophosphamide and reproductive function. Lancet 1971; 1: 1212–4
   Google Scholar
• Warne GL, Fairly KF, Nobbs JB, et al. Cyclophosphamide induced ovarian failure. N Engl J. Med 1973; 289: 1159–62
   PubMed Web of Science ®Google Scholar
• Mattison D, Chang O, Throgeirsson S, et al. The effects of cyclophosphamide azathioprine and 6-mercaptopurine on oocyte and follicular number in C57 BL/6N mice. Res Commun Chem Pathol Pharmacol 1981; 32: 155–61
   Google Scholar
• Ataya KM, McKanna JA, Weintraub AM, et al. A prevention of chemotherapy-induced ovarian follicular loss in rats. Cancer Res 1985; 45: 3651–6
   PubMed Web of Science ®Google Scholar
• Ramahi-Ataya A, Ataya KM, Subramanian M, et al. The effect of ‘activated’ cyclophosphamide on rat granulosa cells in vitro. Reprod Toxicol 1988; 2: 99–103
   PubMedGoogle Scholar
• Ataya KM, Pydyn E, Struck R. Low concentrations of ‘activated’ cyclophosphamide inhibit progesterone (PROG) accumulation in long term granulosa cell (GC) cultures. The American Fertility Society Meeting, Atlanta, 1988
   Google Scholar
• Ataya K, Rao LV, Laurence E, et al. Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide induced ovarian follicular depletion in rhesus monkeys. Biol Reprod 1995; 52: 365–72
   PubMed Web of Science ®Google Scholar
• Blumenfeld Z, Avivi I, Linn S, et al. Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy. Hum Reprod 1996; 11: 1620–6
   PubMed Web of Science ®Google Scholar
• Kreuser ED, Felsenberg D, Behles C, et al. Long term gonadal dysfunction and its impact on bone mineralization in patients following COPP/ABVD chemotherapy for Hodgkin disease. Ann Oncol 1992; 3(Suppl 4)S105–10
   PubMedGoogle Scholar
• Ratcliffe MA, Lanham SA, Reid DM, et al. Bone mineral density (BMD) in patients with lymphoma: the effects of chemotherapy, intermittent corticosteroids and premature menopause. Hematol Oncol 1992; 10: 181–7
   PubMed Web of Science ®Google Scholar
• Jarrell JF, McMahon A, Barr RD, et al. The agonist (d-leu-6, des-gly-10)-LHRH-ethylamide does not protect the fecundity of rats exposed to high dose unilateral ovarian irradiation. Reprod Toxicol 1991; 5: 385–8
   PubMed Web of Science ®Google Scholar
• Ataya K, Pydyn E, Ramahi-Ataya A, et al. Is radiation-induced ovarian failure in rhesus monkeys preventable by luteinizing hormone-releasing hormone agonists? Preliminary observations. J Clin Endocrinol Metab 1995; 80: 790–5
   PubMed Web of Science ®Google Scholar
• Whitehead E, Shalets S, Blackedge G, et al. The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease. Cancer 1983; 52: 988–93
   PubMed Web of Science ®Google Scholar
• Kangasniemi M, Wilson G, Wandakishore P, et al. Rapid protection of rat spermatogenic stem cells against procarbazine by treatment with a gonadotropin-releasing hormone antagonist (Nal-Glu) and an antiandrogen (flutamide). Endocrinology 1995; 136: 2881–8
   PubMedGoogle Scholar
• Singh RP, Carr DH. The anatomy and histology of XO human embryos and fetuses. Anat Rec 1966; 155: 369–83
   PubMedGoogle Scholar
• Zinn AR, Page DC, Fisher EM. Turner syndrome: the case of the missing sex chromosome. Trends Genet 1993; 9: 90–3
   PubMed Web of Science ®Google Scholar
• Sarto GE, Therman E, Patau K. X inactivation in a man: a woman with t(Xq –;12q +). Am J Hum Genet 1973; 25: 262–70
   Google Scholar
• Bates A, Howard PJ. Distal long arm deletions of the X chromosome and ovarian failure. J Med Genet 1990; 27: 722–3
   PubMedGoogle Scholar
• Fitch N, Victor JS, Richer C-L, et al. Premature menopause due to a small deletion in the long arm of the X chromosome: a report of three cases and a review. Am J Obstet Gynecol 1982; 142: 968–72
   PubMedGoogle Scholar
• Krauss CM, Turksoy RN, Atkins L, et al. Familial premature ovarian failure due to an interstitial deletion of the long arm of the X-chromosome. N Engl J Med 1987; 317: 125–31
   PubMed Web of Science ®Google Scholar
• Powell CM, Taggart RT, Drumheller TC, et al. Molecular and cytogenetic studies of an X autosome translocation in a patient with premature ovarian failure and review of the literature. Am J Med Genet 1994; 52: 19–26
   PubMed Web of Science ®Google Scholar
• Turner G, Robinson H, Wake S, et al. Dizygous twinning and premature menopause in fragile X syndrome (letter). Lancet 1994; 344: 1500
   Google Scholar
• Conway GS, Hettiarachchi S, Murray A, et al. Fragile X premutations in familial premature ovarian failure. Lancet 1995; 346: 309–10
   PubMed Web of Science ®Google Scholar
• Conway GS, Payne NN, Webb J, et al. Fragile X premutation screening in women with premature ovarian failure. Hum Reprod 1998; 13: 1184–7
   PubMed Web of Science ®Google Scholar
• Vegetti W, Grazia-Tibiletti M, Testa G, et al. Inheritance in idiopathic premature ovarian failure: analysis of 71 cases. Hum Reprod 1998; 13: 1796–800
   PubMed Web of Science ®Google Scholar
• Conway GS. Clinical manifestations of genetic defects affecting gonadotrophins and their receptors. Clin Endocrinol Oxf 1996; 45: 657–3
   PubMed Web of Science ®Google Scholar
• Aittomaki K, Lucena JLD, Pakarinen P, et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotrophic ovarian failure. Cell 1996; 82: 959–68
   Google Scholar
• Kaufman F, Kogut MD, Donnell GN, et al. Ovarian failure in galactosaemia. Lancet 1979; 2: 737–8
   Google Scholar
• Hoefnagel D, Wurster-Hili D, Child EL. Ovarian failure in galactosaemia. Lancet 1979; 2: 1197
   Google Scholar
• Kaufman FR, Kogut MD, Donnell GN, et al. Hypergonadotrophic hypogonadism in female patients with galactosemia. N Engl J Med 1981; 304: 994–8
   Web of Science ®Google Scholar
• Waggoner DD, Buist NRM, Donnell GN. Long term prognosis in galactosaemia: results of a survey of 350 cases. J Inherit Metab Dis 1990; 13: 802–18
   PubMed Web of Science ®Google Scholar
• Levy HL, Driscoll SG, Porensky RS, et al. Ovarian failure in galactosemia. N Engl J Med 1984; 310: 50
   Google Scholar
• Fraser IS, Russel P, Greco S, et al. Resistant ovary syndrome and premature ovarian failure in young women with galactosaemia. Clin Reprod Fertil 1986; 4: 133–8
   PubMedGoogle Scholar
• Rebar RW, Erickson GF, Yen SSC. Idiopathic premature ovarian failure: clinical and endocrine characteristics. Fertil Steril 1982; 37: 35–41
   PubMed Web of Science ®Google Scholar
• Rebar RW, Erickson GF, Coulam CB. Premature ovarian failure. Pathology of Infertility, B Gondos, DH Riddick. Thieme, New York 1987; 123–41
   Google Scholar
• Chen YT, Mattison DR, Feigenbaum I, et al. Reduction in oocyte number following prenatal exposure to a diet high in galactose. Science 1981; 214: 1145–7
   PubMed Web of Science ®Google Scholar
• Bcauvais P, Guilhaumc A. L'insuffisance ovarienne de la galactosemie congenitale. Presse Med 1984; 13: 2685–7
   Google Scholar
• Robinson ACR, Dockeray CJ, Cullen MJ. Hypergonadotrophic hypogonadism in classical galactosaemia: evidence for defective oogenesis. Brit J Obstet Gynaecol 1984; 91: 199–200
   Google Scholar
• Lobo RA. Benefits and risks of estrogen replacement therapy. Am J Obstet Gynecol 1995; 173: 982–9
   PubMed Web of Science ®Google Scholar
• Check JH, Chase JS, Spence M. Pregnancy in premature ovarian failure after therapy with oral contraceptives despite resistance to previous human menopausal gonadotropin therapy. Am J Obstet Gynecol 1989; 160: 114–5
   PubMed Web of Science ®Google Scholar
• Laml T, Huber JC, Albrecht AE, et al. Unexpected pregnancy during hormone-replacement therapy in a woman with elevated follicle-stimulating hormone and amenorrhea. Gynecol Endocrinol 1999; 13: 89–92
   PubMed Web of Science ®Google Scholar
• Check JH, Nowroozi K, Chase JS, et al. Ovulation induction and pregnancies in 100 consecutive women with hypergonadotropic amenorrhea. Fertil Steril 1990; 53: 811–6
   PubMed Web of Science ®Google Scholar
• Surrey ES, Cedars MI. The effect of gonadotropin suppression on the induction of ovulation in premature ovarian failure patients. Fertil Steril 1989; 52: 36–47
   PubMed Web of Science ®Google Scholar
• Nelson LM, Kimzey LM, White BJ, et al. Gonadotropin suppression for the treatment of karyotypically normal spontaneous premature ovarian failure. A controlled trial. Fertil Steril 1992; 57: 50–5
   PubMed Web of Science ®Google Scholar
• Blumenfeld Z, el Halachmi S, Peretz BA, et al. Premature ovarian failure – the prognostic application of autoimmunity on conception after ovulation induction. Fertil Steril 1993; 59: 750–5
   PubMed Web of Science ®Google Scholar
• Richards JS, Ireland JJ, Rao MC, et al. Ovarian follicular development in the rat: Hormone receptor regulation by estradiol, follicle stimulating hormone and luteinizing hormone. Endocrinology 1976; 99: 1562–70
   PubMed Web of Science ®Google Scholar
• Check JH, Wu CH, Check ML. The effect of leuprolide acetate in aiding induction of ovulation in hypergonadotrope hypogonadism: A case report. Fertil Steril 1988; 49: 542–3
   PubMedGoogle Scholar
• Barbarino-Monnier P, Gobert B, Guillet-May F, et al. Ovarian autoimmunity and corticotherapy in an in-vitro fertilization attempt. Hum Reprod 1995; 10: 2006–7
   Google Scholar
• Van Kasteren YM, Braat DD, Hemrika DJ, et al. Corticosteroids do not influence ovarian responsiveness to gonatotropins in patients with premature ovarian failure: a randomized, placebo-controlled trial. Fertil Steril 1999; 71: 90–5
   PubMed Web of Science ®Google Scholar
• Sheu BC, Ho HN, Yang YS. Spontanous pregnancy after pregnancy by oocyte donation due to premature ovarian failure. Hum Reprod 1996; 11: 1359–60
   Google Scholar
• Franco JG, Junior, Baruffi RL, Mauri AL, et al. Donation of oocytes as treatment for infertility in patients with premature ovarian failure. Rev Paul Med 1994; 112: 510–6
   Google Scholar
• Pados G, Camus M, Van Waesberghe L, et al. Oocyte and embryo donation: evaluation of 412 consecutive trials. Hum Reprod 1992; 7: 1111–7
   PubMed Web of Science ®Google Scholar
• Sung L, Bustillo M, Mukherjee T, et al. Sisters of women with premature ovarian failure may not be ideal ovum donors. Fertil Steril 1997; 67: 912–6
   PubMed Web of Science ®Google Scholar
• Newton H, Aubard Y, Rutherford A, et al. Low temperature storage and grafting of human ovarian tissue. Hum Reprod 1996; 11: 1487–91
   PubMed Web of Science ®Google Scholar